论文部分内容阅读
目的观察硝苯地平缓释片联合清肝降压胶囊治疗老年性高血压的疗效。方法 200例老年性高血压患者,随机分为观察组和对照组,各100例。对照组给予硝苯地平缓释片治疗,观察组在此基础上联合清肝降压胶囊治疗。比较两组临床疗效。结果治疗后观察组患者临床症状评分改善程度优于对照组患者,差异具有统计学意义(P<0.05)。观察组治疗总有效率为98.00%,高于对照组的86.00%,差异具有统计学意义(P<0.05)。治疗后,两组患者血压均明显低于治疗前,差异具有统计学意义(P<0.05);且观察组患者改善情况明显优于对照组,差异具有统计学意义(P<0.05)。结论硝苯地平缓释片联合清肝降压胶囊治疗老年性高血压有着较好的临床疗效,不良反应发生率低,治疗效果明显,值得在临床推广应用。
Objective To observe the curative effect of nifedipine sustained release tablets and qingganjiangya capsule on senile hypertension. Methods 200 cases of elderly hypertensive patients were randomly divided into observation group and control group, each 100 cases. The control group was given nifedipine sustained-release tablets, and the observation group was treated with qingganjiangya capsule on this basis. The clinical efficacy of the two groups were compared. Results After treatment, the scores of clinical symptom scores in observation group were better than those in control group, the difference was statistically significant (P <0.05). The total effective rate of the observation group was 98.00%, which was higher than that of the control group (86.00%), the difference was statistically significant (P <0.05). After treatment, the blood pressure of the two groups were significantly lower than before treatment, the difference was statistically significant (P <0.05); and the observation group patients improved significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion Nifedipine sustained-release tablets combined with Qingganjiangya Capsules in the treatment of senile hypertension has a good clinical efficacy, low incidence of adverse reactions, the treatment effect is obvious, it is worth in the clinical application.